SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,894,879 | -13.6% | 400,164 | -21.6% | 0.10% | -9.8% |
| Q2 2023 | $98,266,779 | -2.1% | 510,583 | +3.0% | 0.11% | -3.4% |
| Q1 2023 | $100,382,803 | +73.3% | 495,791 | +10.0% | 0.12% | +68.1% |
| Q4 2022 | $57,939,807 | -18.8% | 450,860 | -13.6% | 0.07% | -25.8% |
| Q3 2022 | $71,388,000 | +2.1% | 521,726 | +32.0% | 0.09% | +8.1% |
| Q2 2022 | $69,913,000 | -1.2% | 395,124 | -19.5% | 0.09% | +19.4% |
| Q1 2022 | $70,732,000 | -24.7% | 491,025 | -19.2% | 0.07% | -20.9% |
| Q4 2021 | $93,906,000 | -5.3% | 607,415 | +4.0% | 0.09% | -15.0% |
| Q3 2021 | $99,190,000 | +10.7% | 584,159 | +3.0% | 0.11% | +10.3% |
| Q2 2021 | $89,568,000 | +28.2% | 567,394 | +12.8% | 0.10% | +14.1% |
| Q1 2021 | $69,839,000 | -29.1% | 502,946 | -10.6% | 0.08% | -35.1% |
| Q4 2020 | $98,562,000 | – | 562,759 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |